Paul Schumann
Overview
Explore the profile of Paul Schumann including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
50
Citations
459
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roessler J, Zimmermann F, Schumann P, Nageswaran V, Ramezani Rad P, Schuchardt S, et al.
Nutrients
. 2024 Jul;
16(14.
PMID: 39064811
(1) Background: Dyslipidemia represents a major risk factor for atherosclerosis-driven cardiovascular disease. Emerging evidence suggests a close relationship between cholesterol metabolism and gut microbiota. Recently, we demonstrated that the short-chain...
2.
Kundert D, Tavassol F, Kampmann A, Gellrich N, Lindhorst D, Precht M, et al.
Heliyon
. 2023 Sep;
9(9):e19468.
PMID: 37681156
Objectives: Bisphosphonates are known to induce a severe adverse effect known as medication-related osteonecrosis of the jaw (MRONJ). Previous studies have proven the impact of bisphosphonates on microperfusion; therefore, this...
3.
Getzmann J, Huber F, Nakhostin D, Deininger-Czermak E, Schumann P, Finkenstaedt T, et al.
Eur J Radiol Open
. 2022 May;
9:100421.
PMID: 35494189
Objectives: To assess the impact on bone depiction quality by decreasing number of radial acquisitions (RA) of a UTE MR bone imaging sequence in MRONJ. Material And Methods: UTE MR...
4.
Haghikia A, Zimmermann F, Schumann P, Jasina A, Roessler J, Schmidt D, et al.
Eur Heart J
. 2021 Oct;
43(6):518-533.
PMID: 34597388
Aims: Atherosclerotic cardiovascular disease (ACVD) is a major cause of mortality and morbidity worldwide, and increased low-density lipoproteins (LDLs) play a critical role in development and progression of atherosclerosis. Here,...
5.
Schumann P, Morgenroth S, Huber F, Rupp N, Del Grande F, Guggenberger R
Dentomaxillofac Radiol
. 2021 Aug;
51(2):20210036.
PMID: 34406841
Objectives: To investigate whether dynamic contrast-enhanced (DCE)-MR bone perfusion could serve as surrogate for morphologic ultra-short echo time (UTE) bone images and to correlate perfusion with morphologic hallmarks in histologically...
6.
Mehra T, Schonegg D, Ebner J, Moos R, Schumann P, Gander T, et al.
Swiss Med Wkly
. 2021 May;
151:w20497.
PMID: 33934317
Background: Reconstruction of osseous and soft tissue defects after surgical resection of oral cavity cancers can be achieved by a single-stage procedure with a microvascular bone flap or by a...
7.
Stadlinger B, Essig H, Schumann P, van Waes H, Valdec S, Winklhofer S
Swiss Dent J
. 2021 Feb;
131(2):133-139.
PMID: 33559983
Cinematic rendering (CR) is a novel 3D visualisation technique, which provides photorealistic image reconstructions with a high level of image details. Aim of this case series is to show the...
8.
Thiel Y, Ghayor C, Lindhorst D, Essig H, Weber F, Rucker M, et al.
Pathol Res Pract
. 2020 Oct;
216(12):153245.
PMID: 33065485
Bisphosphonates and denosumab are commonly used antiresorptive therapies in patients with bone metastasis and osteoporosis. Medication-related osteonecrosis of the jaw (MRONJ) is a serious side effect of these drugs, and...
9.
Morand G, Broglie M, Schumann P, Huellner M, Rupp N
Front Oncol
. 2020 Sep;
10:1670.
PMID: 32984043
Introduction: Fluorodeoxyglucose-positron emission tomography (FDG-PET) is a widely used imaging tool for oral squamous cell carcinoma (OSCC). Preliminary studies indicate that quantification of tumor metabolic uptake may correlate with tumor...
10.
Hennecke M, Schumann P, Specht J
Psychol Aging
. 2020 Sep;
35(7):1000-1015.
PMID: 32881547
People differ from each other in their typical patterns of behavior, thought, and emotion and these patterns are considered to constitute their personalities (Funder, 2001). For various reasons, for example,...